tTG-IgA (tissue transglutaminase antibodies) is a well-established biomarker for celiac disease. A common myth is that a positive tTG-IgA test automatically means celiac disease with skin involvement (dermatitis herpetiformis). Fact: tTG-IgA is specific for celiac disease, but not every celiac patient develops skin symptoms. Dermatitis herpetiformis is a distinct manifestation caused by IgA deposits in the skin and is also associated with tTG-IgA. Another myth: tTG-IgA can be reliably diagnosed from a home blood test alone. Fact: A positive result always requires confirmation via duodenal biopsy and/or HLA typing, as false positives can occur (e.g., in other autoimmune conditions). Moreover, consumer tests without medical interpretation can lead to misinterpretation. The evidence linking tTG-IgA to celiac disease is strong (human-strong), but the translation to skin symptoms is not universal. Safety note: If celiac disease or dermatitis herpetiformis is suspected, a specialist (gastroenterology/dermatology) should always be consulted before starting a gluten-free diet.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-12b8901f4c33841dbb6b918f